• Are biosimilars really cheaper?
    Biologics have superior efficacy but are also expensive; this has paved way for a lucrative and rapidly expanding market for biosimilars, which are perceived to help bring down healthcare costs.
  • World Tuberculosis Day: A look at one of the most infectious diseases
    Tuberculosis is one of the top 10 causes of death worldwide. In 2015, 10.4 million were diagnosed with tuberculosis and an estimated 1.8 million died from the disease.
  • 3 less known nursing specialisations to consider as a career
    There are more career possibilities for nurses who are not certain about what they can do in the field of nursing.
  • Mushroom poisoning: 3 common myths busted
    Hong Kong is one of the regions in Asia which has a huge consumption of mushrooms. However, according to the Hong Kong Poison Information Centre, 67 cases of mushroom poisoning were reported from 1 July 2005 to 30 June 2015, and the number is on the rise. In this article, we revisit some common myths to prevent such poisoning cases from happening any longer.
  • How community pharmacies can stay organised
    Community pharmacies need to be well-organised in order to provide high-quality service to the community. Here are some tips to help.
  • Doctor consults YouTube video for emergency procedure causing patient death
    A family doctor has been sued for failing to provide timely and proper care to a patient, and even had to watch a YouTube video for instructions, ultimately costing the patient his life.
  • Science Bites: 4 biotypes of depression found using fMRI, Fructose conversion in brain linked to neurological problems
    Researchers have identified biomarkers which distinguish neurophysiological subtypes of depression using brain imaging. Meanwhile, conversion of glucose to fructose in the brain via the polyol pathway may be linked to neurological complications in diabetics.
  • For patient safety, the FDA needs to enact one crucial rule next month
    Brand-name drug makers are allowed to update product labels after learning about potentially harmful side effects and generic companies are only allowed to do so afterwards. The FDA is set to review this rule to allow generic companies to update labels as soon as they learn about new side effects. But will the rule ever be enacted?
  • Patient-led research may be the future of medical studies
    Researchers are slowly finding that by allowing patients to dictate what gets researched, problems previously not recognised can be identified and research becomes more focused and efficient.
  • 4 common misconceptions about biosimilar drugs
    There are many misconceptions regarding biosimilar drugs because the approval process, relevant legislation regarding interchangeability of biologics and pricing mechanisms are subjected to continuous modification.